|
CLS Cell Lines Service GmbH
bt474 cells ![]() Bt474 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bt474 cells/product/CLS Cell Lines Service GmbH Average 93 stars, based on 1 article reviews
bt474 cells - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
|
AMS Biotechnology
bt474 ![]() Bt474, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bt474/product/AMS Biotechnology Average 98 stars, based on 1 article reviews
bt474 - by Bioz Stars,
2026-02
98/100 stars
|
Buy from Supplier |
|
Korean Cell Line Bank
human breast cancer cell line bt-474 ![]() Human Breast Cancer Cell Line Bt 474, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human breast cancer cell line bt-474/product/Korean Cell Line Bank Average 90 stars, based on 1 article reviews
human breast cancer cell line bt-474 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
AstraZeneca ltd
bt474 cells ![]() Bt474 Cells, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bt474 cells/product/AstraZeneca ltd Average 90 stars, based on 1 article reviews
bt474 cells - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
iCell Gene Therapeutics
mda-mb-231 cell lines icell-h133 ![]() Mda Mb 231 Cell Lines Icell H133, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mda-mb-231 cell lines icell-h133/product/iCell Gene Therapeutics Average 90 stars, based on 1 article reviews
mda-mb-231 cell lines icell-h133 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Novartis
bt474 cell line ![]() Bt474 Cell Line, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bt474 cell line/product/Novartis Average 90 stars, based on 1 article reviews
bt474 cell line - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Multiplexion GmbH
human cell lines bt474 and a431 ![]() Human Cell Lines Bt474 And A431, supplied by Multiplexion GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human cell lines bt474 and a431/product/Multiplexion GmbH Average 90 stars, based on 1 article reviews
human cell lines bt474 and a431 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Snijders Scientific
breast cancer cell line bt474 ![]() Breast Cancer Cell Line Bt474, supplied by Snijders Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/breast cancer cell line bt474/product/Snijders Scientific Average 90 stars, based on 1 article reviews
breast cancer cell line bt474 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Beuth Verlag GmbH
human ductal breast carcinoma cell line bt474 ![]() Human Ductal Breast Carcinoma Cell Line Bt474, supplied by Beuth Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human ductal breast carcinoma cell line bt474/product/Beuth Verlag GmbH Average 90 stars, based on 1 article reviews
human ductal breast carcinoma cell line bt474 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
UPM Biomedicals
cell line bt474 ![]() Cell Line Bt474, supplied by UPM Biomedicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cell line bt474/product/UPM Biomedicals Average 90 stars, based on 1 article reviews
cell line bt474 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
JCRB Cell Bank
bt474 cells ![]() Bt474 Cells, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bt474 cells/product/JCRB Cell Bank Average 90 stars, based on 1 article reviews
bt474 cells - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
IDEXX
bt474 cell line ![]() Bt474 Cell Line, supplied by IDEXX, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bt474 cell line/product/IDEXX Average 90 stars, based on 1 article reviews
bt474 cell line - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Breast Cancer : Targets and Therapy
Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
doi: 10.2147/BCTT.S322619
Figure Lengend Snippet: MTT-assay. ( A ) MTT-assay T-47D cells, ( B ) MTT-assay BT474 cells, ( C ) MTT-assay MDA-MB-231 cells.
Article Snippet:
Techniques: MTT Assay
Journal: Breast Cancer : Targets and Therapy
Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
doi: 10.2147/BCTT.S322619
Figure Lengend Snippet: Ki67 in T-47D, MDA-MB-231 and BT474 cells. Relative intracellular expression of Ki67 RNA in T-47D cells ( A ), MDA-MB-231 cells ( B ) and BT474 cells ( C ) after treatment with 50µM citral (Cit), 50µM citrathal R (CR) and 50µM Cyclovertal (Cy). CTRL: DMSO-Control.
Article Snippet:
Techniques: Expressing
Journal: Breast Cancer : Targets and Therapy
Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
doi: 10.2147/BCTT.S322619
Figure Lengend Snippet: Survivin in T-47D, MDA-MB-231 and BT474 cells. Relative intracellular expression of survivin RNA in T-47D cells ( A ), MDA-MB-231 cells ( B ) and BT474 cells ( C ) after treatment with 50µM citral (Cit), 50µM citrathal R (CR) and 50µM Cyclovertal (Cy). CTRL: DMSO-Control.
Article Snippet:
Techniques: Expressing
Journal: Breast Cancer : Targets and Therapy
Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
doi: 10.2147/BCTT.S322619
Figure Lengend Snippet: Cyclin A2 in T47-D, MDA-MB-231 and BT474 cells. Relative intracellular expression of cyclin A2 RNA in T-47D cells ( A ), MDA-MB-231 cells ( B ) and BT474 cells ( C ) after treatment with 50µM citral (Cit), 50µM citrathal R (CR) and 50µM Cyclovertal (Cy). CTRL: DMSO-Control.
Article Snippet:
Techniques: Expressing
Journal: Breast Cancer : Targets and Therapy
Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
doi: 10.2147/BCTT.S322619
Figure Lengend Snippet: Western blots. Western Blot showing control, capsazepine alone, citral, citral + capsazepine, citrathal R, citrathal R + capsazepine, cyclovertal and cyclovertal + capsazepine. ß-tubulin served as loading control in ( A ) T-47D, ( B ) BT474, ( C ) MDA-MB-231.
Article Snippet:
Techniques: Western Blot
Journal: Breast Cancer : Targets and Therapy
Article Title: Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
doi: 10.2147/BCTT.S322619
Figure Lengend Snippet: Immunocytochemistry. 1: T-47D PCNA. Immunocytochemical staining of T47D cells with PCNA antibody (dilution 1:7500, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced nuclear–cytoplasmic ratio and increased nuclear condensation. 2: T-47D Annexin V. Immunocytochemical staining of T47D cells with Annexin V antibody (dilution 1:250, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced nuclear–cytoplasmic ratio and increased nuclear condensation. Slightly increased staining of the outer cell membrane after citral treatment, more after citrathal R and cyclovertal, compared to the control. 3: BT474 PCNA. Immunocytochemical staining of BT474 cells with PCNA antibody (dilution 1:7500, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced nuclear–cytoplasmic ratio and increased nuclear condensation. 4: BT474 Annexin V. Immunocytochemical staining of BT474 cells with Annexin V antibody (dilution 1:250, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Clearly increased staining of the outer cell membrane after citral, cylovertal and mostly after citrathal R treatment compared to the control. 5: MDA-MB-231 PCNA. Immunocytochemical staining of MDA-MB-231 cells with PCNA antibody (dilution 1:7500, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced condensation and increased fragmentation of the nucleus and loss of spindle-shape after treatment mostly with citral and citrathal R, but also cyclovertal. Less intensive staining of the nuclei after treatment with citral, citrathal R and cyclovertal compared to the control. 6: MDA-MB-231 Annexin V. Immunohistochemical staining of MDA-MB-231 cells with Annexin V antibody (dilution 1:250, microscopic enlargement 400x). (a) control, (b) citral, (c) citrathal R, (d) cyclovertal. Compared to control reduced condensation and increased fragmentation of the nucleus and loss of spindle-shape after treatment with citral, citrathal R and cyclovertal. Increased staining of the outer cell membrane after citral, citrathal R and mostly after cyclovertal treatment compared to the control.
Article Snippet:
Techniques: Immunocytochemistry, Staining, Immunohistochemical staining
Journal: Nucleic acids research
Article Title: Spatially multiplexed RNA in situ hybridization to reveal tumor heterogeneity.
doi: 10.1093/nar/gkz1151
Figure Lengend Snippet: Figure 1. Local RNA in situ hybridization. (A) Schematic overview of a microfluidic implementation of chromogenic RNA in situ hybridization. The initial preparation of the tissue section including paraffin removal (1), heat (2) and protease (3) pretreatment, as well as fixation was performed globally. The primary probe was then hybridized locally to the RNA of interest (4). In this case the detection of HER2 is shown with internal negative (dapB) and positive (ActB) controls. Finally, the amplification of the signal using preamplifier and amplifier strands (5), the binding of enzyme (6), and the enzymatic reactions (7) were performed globally on the whole slide. (B) Fluorescence images of RNA-ISH experiments detecting the gene expression of HER2 in cell pellet sections of the breast cancer cell lines MCF7 (left), SKBR3 (center) and BT474 (right). Probes directed against bacterial dapB and ActB were used as negative and positive controls, respectively. Scale bar: 100 m.
Article Snippet: FFPE cell blocks and tissues FFPE cell blocks of the cell lines MCF7,
Techniques: RNA In Situ Hybridization, Amplification, Binding Assay, Fluorescence, Gene Expression
Journal: Nucleic acids research
Article Title: Spatially multiplexed RNA in situ hybridization to reveal tumor heterogeneity.
doi: 10.1093/nar/gkz1151
Figure Lengend Snippet: Figure 2. Detection of HER2 expression status by RNA in situ hybridization using internal positive and negative controls. (A) Fluorescence images of the signals detected for HER2, dapB, and ActB in a mammary carcinoma section. Scale bar: 100 m. (B) Quantitative analysis of the fluorescence intensity of FISH signals detected for HER2, dapB, and ActB integrated per sectioned cell for FFPE sections of the breast cancer cell lines MCF7, SKBR3, and BT474 (see Figure 1) as well as the mammary carcinoma from (A). 100 ms excitation.
Article Snippet: FFPE cell blocks and tissues FFPE cell blocks of the cell lines MCF7,
Techniques: Expressing, RNA In Situ Hybridization, Fluorescence
Journal: Nucleic acids research
Article Title: Spatially multiplexed RNA in situ hybridization to reveal tumor heterogeneity.
doi: 10.1093/nar/gkz1151
Figure Lengend Snippet: Figure 3. Single color multiplexed RNA-ISH for the detection of breast cancer biomarkers. (A) The primary probes for ER, PgR, and HER2 were delivered to spatially distinct regions of a mammary carcinoma section using a microfluidic chip (schematic in upper left corner). Fluorescence images of the signal detected for the breast cancer biomarkers ER, PgR and HER2 in a mammary carcinoma section. Scale bar: 100 m. (B) Fluorescence intensity of FISH signals detected for ER, PgR and HER2 integrated per sectioned cell for FFPE sections of the breast cancer cell lines MCF7, SKBR3 and BT474 (see Supplementary Figure S7) as well as the mammary carcinoma from (A). 500 ms excitation.
Article Snippet: FFPE cell blocks and tissues FFPE cell blocks of the cell lines MCF7,
Techniques: Fluorescence
Journal:
Article Title: High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides
doi: 10.1136/jcp.2003.013029
Figure Lengend Snippet: Microarray comparative genomic hybridisation (CGH) profile of the BT474 cell line. (A) Bacterial/phage artificial chromosome polymerase chain reaction representations were used as probe DNAs spotted on to the glass slide; (B) oligonucleotides were used as probe DNAs spotted on to the glass slide. Moving average applied to the log2 ratio of the oligo CGH profile. The vertical bars indicate the spacing between the chromosomes.
Article Snippet: Genomic DNA was isolated from normal kidney (female donor), blood (male donor), or liver (female donor) as a reference, and from the
Techniques: Microarray, Hybridization, Polymerase Chain Reaction
Journal:
Article Title: High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides
doi: 10.1136/jcp.2003.013029
Figure Lengend Snippet: Microarray comparative genomic hybridisation (CGH) profile of the long arm of chromosome 17 of the BT474 cell line. Grey triangles, bacterial/phage artificial chromosome polymerase chain reaction representations were used as probe DNAs spotted on to the glass slide; black squares, oligonucleotides were used as probe DNAs spotted on to the glass slide (log2 ratio without moving average). The horizontal bars indicate the two separate amplicons observed.
Article Snippet: Genomic DNA was isolated from normal kidney (female donor), blood (male donor), or liver (female donor) as a reference, and from the
Techniques: Microarray, Hybridization, Polymerase Chain Reaction
Journal: BioMed Research International
Article Title: Preclinical and Clinical Effects of Mistletoe against Breast Cancer
doi: 10.1155/2014/785479
Figure Lengend Snippet: Summary of in vitro and in vivo studies of mistletoe extracts on breast cancer cells and animal models.
Article Snippet: In 2006,
Techniques: In Vitro, In Vivo, Activity Assay, Purification, Inhibition, Transplantation Assay
Journal: American Journal of Cancer Research
Article Title: KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival
doi:
Figure Lengend Snippet: KRAS signaling was functioning in the breast cancer cell lines. A. Up-regulation of KRAS expression in breast cancer cell lines when compared with MCF10A. Densitometric values were calculated for KRAS. B. Cell growth suppression after transfection of MB231 cells with MEK inhibitor or PI3K inhibitor at 72 H. Comb: PI3Ki 1 + MEKi 5 (μM). *P < 0.05; **P < 0.01; ***P < 0.001.
Article Snippet: Cell culture MCF10A, MCF7, SKBR3, BT474, and
Techniques: Expressing, Transfection